G Sutsch
Overview
Explore the profile of G Sutsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
498
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kunz I, Spada S, Sutsch G, Ruggieri F
Praxis (Bern 1994)
. 2005 May;
94(15):599-603.
PMID: 15884726
We describe the case of a 45-year-old male smoker who presented with an acute anterior wall myocardial infarction and a platelet count on admission of 1030000/mm3. Emergent coronary angiography revealead...
2.
Sutsch G, Amann F, Maggiorini M, Kiowski W
Ther Umsch
. 2002 Mar;
59(2):82-6.
PMID: 11887554
Recent advances in the recognition and the treatment of acute coronary syndromes (ACS) have lead to an improvement in patient survival and definition of newer guidelines. Current strategies for the...
3.
Brunner-La Rocca H, Kiowski W, Ramsay D, Sutsch G
Cardiovasc Res
. 2001 Jul;
51(3):510-20.
PMID: 11476741
Natriuretic peptides play an important role in water and salt homeostasis and in the regulation of the cardiovascular system. In recent years, exogenous administration of natriuretic peptides has primarily been...
4.
Kiowski W, Sutsch G, Oechslin E, Bertel O
Heart Fail Rev
. 2001 Jul;
6(4):325-34.
PMID: 11447307
A role of the potent and long-acting vasoconstrictor peptide endothelin-1 and the pathophysiology of chronic human heart failure has been postulated based upon indirect evidence such as elevated plasma endothelin-1...
5.
Muntwyler J, Sutsch G, Kim J, Schmid H, Follath F, Kiowski W, et al.
Swiss Med Wkly
. 2001 Jun;
131(15-16):214-8.
PMID: 11400544
Background: There is evidence that elevated post-prandial lipoproteins adversely affect progression and outcome of cardiovascular disease. Traditional risk factors are associated with impaired endothelium-mediated vasodilatation. However, studies regarding the relationship...
6.
Bracht C, Yan X, Brunner-Larocca H, Sutsch G, Amann F, Kiowski W
J Hypertens
. 2001 Jun;
19(5):899-905.
PMID: 11393673
Objective: The dihydropyridine calcium antagonist isradipine has anti-atherosclerotic effects in animals and improves endothelium-mediated nitric oxide (NO)-dependent vasodilation in vitro. As improved endothelial function may be beneficial we investigated its...
7.
Kiowski W, Sutsch G
Curr Cardiol Rep
. 2001 Apr;
3(3):232-40.
PMID: 11305978
A role of the potent and long-acting vasoconstrictor peptide endothelin-1 in the pathophysiology of chronic human heart failure has been postulated based on indirect evidence such as elevated plasma endothelin-1...
8.
Julius B, Attenhofer Jost C, Sutsch G, Brunner H, Kuenzli A, Vogt P, et al.
Transplantation
. 2001 Feb;
69(5):847-53.
PMID: 10755538
Background: Cardiac allograft vasculopathy after heart transplantation leads to an accelerated form of atherosclerosis with marked and often diffuse vessel wall changes that limit long-term survival. Previous studies showed contradictory...
9.
Sutsch G, Kiowski W, Bossard A, Luscher T, Maier W, Vogt P, et al.
Schweiz Med Wochenschr
. 2000 Sep;
130(33):1135-45.
PMID: 11005103
Background: Prevention of distal embolisation during percutaneous coronary revascularisation may be necessary to reduce postinterventional morbidity and mortality. Methods And Results: We employed a newly developed emboli containment and retrieval...
10.
Sutsch G, Barton M
Curr Hypertens Rep
. 2000 Sep;
1(1):62-8.
PMID: 10981044
Congestive heart failure is a complex disease that results from pumping failure of the cardiac muscle and adaptational processes of the cardiovascular system to correct for the reduced blood supply...